HSV epigenetics (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "HSV epigenetics" in English language version.

refsWebsite

Global rank English rank

27nih.gov

4^th place

17doi.org

2^nd place

1semanticscholar.org

11^th place

8^th place

1worldcat.org

5^th place

1uanl.mx

low place

doi.org

Knipe DM, Cliffe A (March 2008). "Chromatin control of herpes simplex virus lytic and latent infection". Nature Reviews. Microbiology. 6 (3): 211–21. doi:10.1038/nrmicro1794. PMID 18264117. S2CID 14540640.
Lieberman PM (May 2016). "Epigenetics and Genetics of Viral Latency". Cell Host & Microbe. 19 (5): 619–28. doi:10.1016/j.chom.2016.04.008. PMC 5166714. PMID 27173930.
Balakrishnan L, Milavetz B (November 2017). "Epigenetic Regulation of Viral Biological Processes". Viruses. 9 (11): 346. doi:10.3390/v9110346. PMC 5707553. PMID 29149060.
Speck SH, Ganem D (July 2010). "Viral latency and its regulation: lessons from the gamma-herpesviruses". Cell Host & Microbe. 8 (1): 100–15. doi:10.1016/j.chom.2010.06.014. PMC 2914632. PMID 20638646.
Bryan-Marrugo OL, Ramos-Jiménez J, Barrera-Saldaña H, Rojas-Martínez A, Vidaltamayo R, Rivas-Estilla AM (2015). "History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C". Medicina Universitaria. 17 (68): 165–174. doi:10.1016/j.rmu.2015.05.003.
Brady RC, Bernstein DI (February 2004). "Treatment of herpes simplex virus infections". Antiviral Research. 61 (2): 73–81. doi:10.1016/j.antiviral.2003.09.006. PMID 14670580.
Tsai K, Messick TE, Lieberman PM (October 2015). "Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme". Current Opinion in Virology. 14: 30–40. doi:10.1016/j.coviro.2015.07.008. PMC 4628856. PMID 26256000.
Jung YJ, Choi H, Kim H, Lee SK (August 2014). "MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1". Journal of Virology. 88 (16): 9027–37. doi:10.1128/jvi.00721-14. PMC 4136301. PMID 24899173.
Cliffe AR, Arbuckle JH, Vogel JL, Geden MJ, Rothbart SB, Cusack CL, Strahl BD, Kristie TM, Deshmukh M (December 2015). "Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation". Cell Host & Microbe. 18 (6): 649–58. doi:10.1016/j.chom.2015.11.007. PMC 4681005. PMID 26651941.
Sawtell NM, Triezenberg SJ, Thompson RL (December 2011). "VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo". Journal of Neurovirology. 17 (6): 546–51. doi:10.1007/s13365-011-0065-y. PMC 3269237. PMID 22144074.
Kristie TM (December 2012). "The rise of epigenetic targets for the development of novel antivirals". Expert Review of Anti-Infective Therapy. 10 (12): 1359–61. doi:10.1586/eri.12.143. PMC 4780314. PMID 23253311.
Arbuckle JH, Gardina PJ, Gordon DN, Hickman HD, Yewdell JW, Pierson TC, Myers TG, Kristie TM (August 2017). "Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens". mBio. 8 (4): e01141–17. doi:10.1128/mbio.01141-17. PMC 5559635. PMID 28811345.
Kennedy EM, Courtney DG, Tsai K, Cullen BR (May 2017). "Viral Epitranscriptomics". Journal of Virology. 91 (9): e02263–16. doi:10.1128/JVI.02263-16. PMC 5391447. PMID 28250115.
Karikó K, Buckstein M, Ni H, Weissman D (August 2005). "Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA". Immunity. 23 (2): 165–75. doi:10.1016/j.immuni.2005.06.008. PMID 16111635.
Durbin AF, Wang C, Marcotrigiano J, Gehrke L (September 2016). "RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling". mBio. 7 (5): e00833–16. doi:10.1128/mBio.00833-16. PMC 5030355. PMID 27651356.
Bader JP, Brown NR, Chiang PK, Cantoni GL (September 1978). "3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells". Virology. 89 (2): 494–505. doi:10.1016/0042-6822(78)90191-5. PMID 213879.
de Clercq E, Montgomery JA (March 1983). "Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine". Antiviral Research. 3 (1): 17–24. doi:10.1016/0166-3542(83)90011-6. PMID 6307139.

nih.gov

pubmed.ncbi.nlm.nih.gov

Knipe DM, Cliffe A (March 2008). "Chromatin control of herpes simplex virus lytic and latent infection". Nature Reviews. Microbiology. 6 (3): 211–21. doi:10.1038/nrmicro1794. PMID 18264117. S2CID 14540640.
Lieberman PM (May 2016). "Epigenetics and Genetics of Viral Latency". Cell Host & Microbe. 19 (5): 619–28. doi:10.1016/j.chom.2016.04.008. PMC 5166714. PMID 27173930.
Balakrishnan L, Milavetz B (November 2017). "Epigenetic Regulation of Viral Biological Processes". Viruses. 9 (11): 346. doi:10.3390/v9110346. PMC 5707553. PMID 29149060.
Speck SH, Ganem D (July 2010). "Viral latency and its regulation: lessons from the gamma-herpesviruses". Cell Host & Microbe. 8 (1): 100–15. doi:10.1016/j.chom.2010.06.014. PMC 2914632. PMID 20638646.
Brady RC, Bernstein DI (February 2004). "Treatment of herpes simplex virus infections". Antiviral Research. 61 (2): 73–81. doi:10.1016/j.antiviral.2003.09.006. PMID 14670580.
Tsai K, Messick TE, Lieberman PM (October 2015). "Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme". Current Opinion in Virology. 14: 30–40. doi:10.1016/j.coviro.2015.07.008. PMC 4628856. PMID 26256000.
Jung YJ, Choi H, Kim H, Lee SK (August 2014). "MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1". Journal of Virology. 88 (16): 9027–37. doi:10.1128/jvi.00721-14. PMC 4136301. PMID 24899173.
Cliffe AR, Arbuckle JH, Vogel JL, Geden MJ, Rothbart SB, Cusack CL, Strahl BD, Kristie TM, Deshmukh M (December 2015). "Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation". Cell Host & Microbe. 18 (6): 649–58. doi:10.1016/j.chom.2015.11.007. PMC 4681005. PMID 26651941.
Sawtell NM, Triezenberg SJ, Thompson RL (December 2011). "VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo". Journal of Neurovirology. 17 (6): 546–51. doi:10.1007/s13365-011-0065-y. PMC 3269237. PMID 22144074.
Kristie TM (December 2012). "The rise of epigenetic targets for the development of novel antivirals". Expert Review of Anti-Infective Therapy. 10 (12): 1359–61. doi:10.1586/eri.12.143. PMC 4780314. PMID 23253311.
Arbuckle JH, Gardina PJ, Gordon DN, Hickman HD, Yewdell JW, Pierson TC, Myers TG, Kristie TM (August 2017). "Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens". mBio. 8 (4): e01141–17. doi:10.1128/mbio.01141-17. PMC 5559635. PMID 28811345.
Kennedy EM, Courtney DG, Tsai K, Cullen BR (May 2017). "Viral Epitranscriptomics". Journal of Virology. 91 (9): e02263–16. doi:10.1128/JVI.02263-16. PMC 5391447. PMID 28250115.
Karikó K, Buckstein M, Ni H, Weissman D (August 2005). "Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA". Immunity. 23 (2): 165–75. doi:10.1016/j.immuni.2005.06.008. PMID 16111635.
Durbin AF, Wang C, Marcotrigiano J, Gehrke L (September 2016). "RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling". mBio. 7 (5): e00833–16. doi:10.1128/mBio.00833-16. PMC 5030355. PMID 27651356.
Bader JP, Brown NR, Chiang PK, Cantoni GL (September 1978). "3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells". Virology. 89 (2): 494–505. doi:10.1016/0042-6822(78)90191-5. PMID 213879.
de Clercq E, Montgomery JA (March 1983). "Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine". Antiviral Research. 3 (1): 17–24. doi:10.1016/0166-3542(83)90011-6. PMID 6307139.

ncbi.nlm.nih.gov

Lieberman PM (May 2016). "Epigenetics and Genetics of Viral Latency". Cell Host & Microbe. 19 (5): 619–28. doi:10.1016/j.chom.2016.04.008. PMC 5166714. PMID 27173930.
Balakrishnan L, Milavetz B (November 2017). "Epigenetic Regulation of Viral Biological Processes". Viruses. 9 (11): 346. doi:10.3390/v9110346. PMC 5707553. PMID 29149060.
Speck SH, Ganem D (July 2010). "Viral latency and its regulation: lessons from the gamma-herpesviruses". Cell Host & Microbe. 8 (1): 100–15. doi:10.1016/j.chom.2010.06.014. PMC 2914632. PMID 20638646.
Tsai K, Messick TE, Lieberman PM (October 2015). "Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme". Current Opinion in Virology. 14: 30–40. doi:10.1016/j.coviro.2015.07.008. PMC 4628856. PMID 26256000.
Jung YJ, Choi H, Kim H, Lee SK (August 2014). "MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1". Journal of Virology. 88 (16): 9027–37. doi:10.1128/jvi.00721-14. PMC 4136301. PMID 24899173.
Cliffe AR, Arbuckle JH, Vogel JL, Geden MJ, Rothbart SB, Cusack CL, Strahl BD, Kristie TM, Deshmukh M (December 2015). "Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation". Cell Host & Microbe. 18 (6): 649–58. doi:10.1016/j.chom.2015.11.007. PMC 4681005. PMID 26651941.
Sawtell NM, Triezenberg SJ, Thompson RL (December 2011). "VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo". Journal of Neurovirology. 17 (6): 546–51. doi:10.1007/s13365-011-0065-y. PMC 3269237. PMID 22144074.
Kristie TM (December 2012). "The rise of epigenetic targets for the development of novel antivirals". Expert Review of Anti-Infective Therapy. 10 (12): 1359–61. doi:10.1586/eri.12.143. PMC 4780314. PMID 23253311.
Arbuckle JH, Gardina PJ, Gordon DN, Hickman HD, Yewdell JW, Pierson TC, Myers TG, Kristie TM (August 2017). "Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens". mBio. 8 (4): e01141–17. doi:10.1128/mbio.01141-17. PMC 5559635. PMID 28811345.
Kennedy EM, Courtney DG, Tsai K, Cullen BR (May 2017). "Viral Epitranscriptomics". Journal of Virology. 91 (9): e02263–16. doi:10.1128/JVI.02263-16. PMC 5391447. PMID 28250115.
Durbin AF, Wang C, Marcotrigiano J, Gehrke L (September 2016). "RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling". mBio. 7 (5): e00833–16. doi:10.1128/mBio.00833-16. PMC 5030355. PMID 27651356.

semanticscholar.org

api.semanticscholar.org

Knipe DM, Cliffe A (March 2008). "Chromatin control of herpes simplex virus lytic and latent infection". Nature Reviews. Microbiology. 6 (3): 211–21. doi:10.1038/nrmicro1794. PMID 18264117. S2CID 14540640.

uanl.mx

eprints.uanl.mx

Bryan-Marrugo OL, Ramos-Jiménez J, Barrera-Saldaña H, Rojas-Martínez A, Vidaltamayo R, Rivas-Estilla AM (2015). "History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C". Medicina Universitaria. 17 (68): 165–174. doi:10.1016/j.rmu.2015.05.003.

worldcat.org

search.worldcat.org

H., Acheson, N. (2011). Fundamentals of molecular virology (2nd ed.). Hoboken, NJ: John Wiley & Sons. ISBN 9780470900598. OCLC 697768676.{{cite book}}: CS1 maint: multiple names: authors list (link)